| TUESDAY, FEBRUARY 09, 2010 |
| 7:15 AM | Biogen Idec Reports Full Year and Fourth Quarter 2009 Results - BusinessWire |
 |
| MONDAY, FEBRUARY 08, 2010 |
| 3:00 PM | Multiple Sclerosis Experts Join Biogen Idec's Research and Development Team - BusinessWire |
|
| 6:00 AM | Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors - PR Newswire |
|
| WEDNESDAY, FEBRUARY 03, 2010 |
| 7:30 AM | William D. Young Joins NanoString Technologies as Executive Chairman of the Board - BusinessWire |
|
| MONDAY, FEBRUARY 01, 2010 |
| 8:08 AM | CPEX Pharmaceuticals Announces Appointment of New Chief Scientific Officer - BusinessWire |
|
| THURSDAY, JANUARY 28, 2010 |
| 8:00 AM | Biogen Idec Receives Notice of Intention to Nominate Directors at 2010 Meeting of Shareholders - BusinessWire |
|
| MONDAY, JANUARY 25, 2010 |
| 12:14 PM | Swedish Orphan Biovitrum says first patient dosed in haemophilia B study - M2 |
|
| 11:12 AM | Swedish Orphan Biovitrum says first patient dosed in haemophilia B study - M2 |
|
| 8:00 AM | PROLOR Biotech Reports Positive Results From Comparative Study of Its Longer-Acting Version of Multiple Sclerosis Drug Interferon Beta in Primates - PR Newswire |
|
| 2:30 AM | Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Acting Hemophilia B Therapy - BusinessWire |
|
